N20
Conditions
Interventions
Group 1: Study participants in the intervention group will receive access to the Uroli app and the Medipee device with urine test strips for 250 determinations at recruitment and before discharge from
Sponsors
Medipee GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with renal/ureteral stone (ICD-10: N20) who require personalized stone metaphylaxis, regardless of stone type and regardless of initial occurrence or recurrence; individuals 18 years of age and older; regular use of a smartphone, including use of apps to ensure usability of the Uroli app; accessibility via e-mail
Exclusion criteria
Exclusion criteria: Patients with acute symptoms of urolithiasis; Patients who are medically judged to be limited in fluid intake due to other medical conditions or patients with markedly impaired renal function as defined by a serum creatinine level >2mg/dl; Individuals who have been determined by an investigator to be unable to participate in the study; Individuals under the age of 18; Not owning or regularly using their own smartphone; Not having their own email address; Individuals without consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study Objective: To evaluate the effectiveness of the Uroli app in supporting metaphylaxis of adult patients with urolithiasis after acute treatment of a renal or ureteral stone compared to metaphylaxis without the Uroli app in terms of medical benefit and patient-relevant structural and procedural improvements. The individual endpoints defined, including the measurement instruments used for this purpose, can be found in the attached study document (" Endpoints"). The measurement variables will be collected at T0 and after 3 months (T1). Translated with www.DeepL.com/Translator (free version) | — |
Countries
Germany
Contacts
Public ContactAlexander Winter
Klinikum Oldenburg, Universitätsklinik für Urologie
Outcome results
None listed